300+ investors in your industry, stage, and region Get
Any industry
EdTech
Venture Capital
Video Games
Hospitality
Restaurants
Crowdfunding
Financial Services
Photography
Construction
Mobile
Big Data
Email
Artificial Intelligence
Clean Energy
Non Profit
Social Impact
Energy
SaaS
Google
CleanTech
Consumer
Health Care
Enterprise Software
Local
Travel
Cryptocurrency
Digital Media
InsurTech
Oil and Gas
Platforms
Retail
Payments
Film
Marketplace
Fitness
Organic Food
Machine Learning
Agriculture (AgTech)
Gaming
Social Network
B2B
Medical Device
Wellness
Education
Sports
Legal
Automotive
eSports
Biotechnology
Renewable Energy
Facebook
Blockchain
Software
Theatre
Medical
Web3
Beauty
Recruiting
Celebrity
Cannabis
LGBT
Climate
Food and Beverage
Life Science
Publishing
Wine and Spirits
Mobile Apps
Real Estate
Fashion
Sporting Goods
Music
Art
Finance
Manufacturing
Infrastructure
FinTech
Social Media
Franchise
Internet
Mobile Advertising
Android
Impact
Proptech
Hardware
Transportation
Social
Biotech
Sustainability
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
Thailand
United Arab Emirates
Andorra
Dominica
Japan
Brazil
Singapore
Burkina Faso
Africa
LATAM
Egypt
United Kingdom
Oceania
Argentina
Tunisia
Faroe Islands
Taiwan
South Korea
Zimbabwe
Hong Kong
Benin
Nigeria
Croatia
Togo
Gibraltar
Guinea
Kyrgyzstan
Sudan
Norway
Malawi
Isle of Man
Iran
Haiti
Lesotho
Madagascar
Russian Federation
Nepal
Pakistan
Turkey
Mexico
Liberia
Tajikistan
Sweden
Romania
Zambia
Oman
Poland
Puerto Rico
Guernsey
Cameroon
Colombia
China
Armenia
Costa Rica
Côte d'Ivoire
Kuwait
Czech Republic
Marshall Islands
Malta
Luxembourg
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Morocco
Australia
Jamaica
Sri Lanka
New Zealand
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uruguay
Uganda
Moldova
Botswana
Seychelles
Paraguay
South Africa
France
Denmark
Ghana
Georgia
Iraq
Sierra Leone
Philippines
Portugal
El Salvador
Senegal
India
Germany
Canada
Ireland
Saudi Arabia
Kenya
Mali
Malaysia
Rwanda
Tanzania
Latvia
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Bangladesh
Spain
Angola
Europe
Cyprus
Qatar
Barbados
Austria
Belgium
Azerbaijan
Ecuador
Bulgaria
Bahamas
Bahrain
Ethiopia
Estonia
Jersey
Bolivia
Belize
Jordan
Algeria
Belarus
Finland
Italy
Hungary
Grenada
Israel
Honduras
Liechtenstein
Lithuania
Lebanon
Mongolia
Iceland
Peru
Slovenia
San Marino
Ukraine
Cambodia
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Jim Greer, Angel Investor

Jim Greer

Angel Investor

San Francisco Bay Area, United States

Jim Greer is a seed investor in San Francisco Bay Area focused on Health Care and Life Science. Jim Greer is the Chief Executive Officer at Bash. He was the co-founder and Chief Executive Officer of Kongregate. Before founding Kongregate in June 2006, Jim was Technical Director for Pogo at Electronic Arts. He has worked in the game industry since 1991.

Total investments:
1
Last investment:
Lead investor:
0%

Last updated:

Industries Jim Greer invests in

Health CareLife ScienceBiotechnologyMedical Device

Stages Jim Greer invests in

Seed

Countries Jim Greer invests in

United States

Contacts

TypeContactValidation
Work email
Personal email
Work phone
Personal phone
Socials

Sign up to unlock verified contacts

Unlock Contacts

Investment Focus

Industry

  • Health Care 1 (100%)
  • Life Science 1 (100%)
  • Biotechnology 1 (100%)
  • Medical Device 1 (100%)

Investments

CompanyDescriptionRoundLinks
Vium is a biotechnology company that develops digital biomarkers to transform preclinical research and animal welfare. It is fully accredited by AAALAC International and received an unprecedented AAALAC commendation for upholding the 3 Rs, the gold-standard framework for humane animal research. Customers run the spectrum of biotechnology,pharmaceutical, and computational drug discovery companies to academia and novel therapeutic labs.Vium's digital platform provides physiological biomarkers that enable better decisions on which compounds should be advanced to the clinic. The company's platform Digital Vivariumand Vium Cloud is the gold-standard in vivo platform combining computer vision, artificial intelligence, machine learning, and sensor technology to non-invasively collect and derive insights from digital biomarkers. The platform continuously captures physiological metrics and behaviors non-invasively, providing more sensitive and accurate data collection, leading to more replicable studies.Vium was founded in 2013 and is headquartered in San Mateo, California, United States. $1.1M / Seed / Mar 01, 2014

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
EdTech
Venture Capital
Video Games
Hospitality
Restaurants
Crowdfunding
Financial Services
Photography
Construction
Mobile
Big Data
Email
Artificial Intelligence
Clean Energy
Non Profit
Social Impact
Energy
SaaS
Google
CleanTech
Consumer
Health Care
Enterprise Software
Local
Travel
Cryptocurrency
Digital Media
InsurTech
Oil and Gas
Platforms
Retail
Payments
Film
Marketplace
Fitness
Organic Food
Machine Learning
Agriculture (AgTech)
Gaming
Social Network
B2B
Medical Device
Wellness
Education
Sports
Legal
Automotive
eSports
Biotechnology
Renewable Energy
Facebook
Blockchain
Software
Theatre
Medical
Web3
Beauty
Recruiting
Celebrity
Cannabis
LGBT
Climate
Food and Beverage
Life Science
Publishing
Wine and Spirits
Mobile Apps
Real Estate
Fashion
Sporting Goods
Music
Art
Finance
Manufacturing
Infrastructure
FinTech
Social Media
Franchise
Internet
Mobile Advertising
Android
Impact
Proptech
Hardware
Transportation
Social
Biotech
Sustainability
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
Thailand
United Arab Emirates
Andorra
Dominica
Japan
Brazil
Singapore
Burkina Faso
Africa
LATAM
Egypt
United Kingdom
Oceania
Argentina
Tunisia
Faroe Islands
Taiwan
South Korea
Zimbabwe
Hong Kong
Benin
Nigeria
Croatia
Togo
Gibraltar
Guinea
Kyrgyzstan
Sudan
Norway
Malawi
Isle of Man
Iran
Haiti
Lesotho
Madagascar
Russian Federation
Nepal
Pakistan
Turkey
Mexico
Liberia
Tajikistan
Sweden
Romania
Zambia
Oman
Poland
Puerto Rico
Guernsey
Cameroon
Colombia
China
Armenia
Costa Rica
Côte d'Ivoire
Kuwait
Czech Republic
Marshall Islands
Malta
Luxembourg
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Morocco
Australia
Jamaica
Sri Lanka
New Zealand
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uruguay
Uganda
Moldova
Botswana
Seychelles
Paraguay
South Africa
France
Denmark
Ghana
Georgia
Iraq
Sierra Leone
Philippines
Portugal
El Salvador
Senegal
India
Germany
Canada
Ireland
Saudi Arabia
Kenya
Mali
Malaysia
Rwanda
Tanzania
Latvia
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Bangladesh
Spain
Angola
Europe
Cyprus
Qatar
Barbados
Austria
Belgium
Azerbaijan
Ecuador
Bulgaria
Bahamas
Bahrain
Ethiopia
Estonia
Jersey
Bolivia
Belize
Jordan
Algeria
Belarus
Finland
Italy
Hungary
Grenada
Israel
Honduras
Liechtenstein
Lithuania
Lebanon
Mongolia
Iceland
Peru
Slovenia
San Marino
Ukraine
Cambodia
Vietnam
Chile
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Jim Greer invest in?

Jim Greer invests primarily in Health Care, Life Science and Biotechnology startups, most often at Seed stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

How do I contact Jim Greer?

Public channels for Jim Greer include LinkedIn, X (Twitter) and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

When did Jim Greer last invest?

The most recent investment recorded for Jim Greer closed in Mar 2014. Shizune tracks 1 investment in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Jim Greer Jim Greer Find email